St George Mining Ltd (ASX:SGQ, FRA:S0G, OTC:SGQMF) has reported more thick, high-grade rare earths and niobium intercepts from diamond drilling at its wholly owned Araxá Rare Earths and Niobium Project in Minas Gerais, Brazil.
The latest assays have again highlighted extensive niobium mineralisation at Araxá, with broad high-grade intervals starting from surface. The company said the strong niobium results reflect the project’s location within the Barreiro Carbonatite, next to CBMM’s operations, the world’s largest niobium producer.
United Natural Foods (NASDAQ:UNFI) reported mixed results for its fourth quarter of calendar 2025, with shares falling about 2.5% following the release.
Revenue for the quarter came in at $7.95 billion, down 2.6% year-over-year and slightly below analyst expectations of $8.11 billion.
374Water Inc (NASDAQ:SCWO, FRA:8LL) announced that it has received approval from the City of Orlando to provide waste destruction services at the Iron Bridge Regional Water Reclamation Facility, marking a step toward expanding the company’s commercial operations for the treatment of organic waste streams.
The cleantech company said the approval grants it a license to operate its Waste Destruction Services platform at the facility for an initial five-year term, with options for two additional five-year extensions.
Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF, FRA:1SS) announced hat it has signed 50 new customer contracts since the start of 2026, representing approximately $230,000 in total contracted value, as adoption of its artificial intelligence-powered event technology platform continues to grow.
The company said the contracts were secured between January and early March and reflect agreements with first-time customers. The figure excludes renewals and expansion revenue from existing clients, which the company noted remains a separate component of its overall revenue.
Argentina Lithium & Energy Corp (TSX-V:LIT, OTCQX:LILIF) announced that it has closed a brokered LIFE (Listed Issuer Financing Exemption) private placement, raising approximately C$4.38 million.
The financing included the partial exercise of the agent’s option and was conducted on a “best efforts” basis, the company said on Tuesday.
AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) highlighted progress across its clinical pipeline and reaffirmed its financial outlook during its 2026 Virtual Investor Day, outlining plans to advance its lead candidate BPL-003 into Phase 3 trials for treatment-resistant depression while continuing development of additional mental health therapies.
The clinical-stage biotechnology company said it remains on track to initiate two parallel Phase 3 pivotal studies of BPL-003, a mebufotenin benzoate nasal spray, in the second quarter of 2026 following a successful End-of-Phase 2 meeting with the US Food and Drug Administration. The drug candidate has received Breakthrough Therapy Designation and is being developed as a rapid-acting treatment for patients with treatment-resistant depression.
Power Metallic Mines Inc (TSX-V:PNPN, FRA:IVV1, OTCQB:PNPNF) reported strong assay results from its fall 2025 drilling program and the first hole of its 2026 winter campaign, highlighting the high-grade potential of its Lion Zone copper discovery.
The company said infill drilling at the Lion Zone continues to demonstrate consistent high-grade copper, supporting plans for a 2026 Mineral Resource Estimate (MRE).
VivoPower International PLC (NASDAQ:VVPR, FRA:51J), a B Corp-certified developer and owner of powered land and data center infrastructure for AI compute applications, said on Tuesday it will change its name to VivoPower PLC and begin trading under the new ticker “VIVO” on March 16, 2026, before the open of trading on the Nasdaq stock market.
The moves reflect the company’s focus on building, owning, and leasing powered land and data center infrastructure, a critical component in the rapidly growing AI sector.
EnWave Corp (TSX-V:ENW, OTC:NWVCF, FRA:E4U) announced that it has entered into a license and equipment purchase agreement with Teagasc, Ireland’s Agriculture and Food Development Authority, to support research and development activities using the company’s dehydration technology.
The company said that the agreement grants Teagasc R&D rights to use EnWave’s proprietary Radiant Energy Vacuum (REV) dehydration technology in collaboration with its current and future clients, as well as industry and research partners.
Ideal Power Inc (NASDAQ:IPWR, FRA:5ILA) is accelerating the commercialization of its B-TRAN bidirectional semiconductor power switch, signing two new customer agreements and positioning the technology for widespread adoption in high-growth power electronics markets.
Ideal Power, reporting results for the fourth quarter and full year ended December 31, 2025, highlighted partnerships and ongoing development programs targeting applications in electric vehicles (EVs), data centers, renewable energy, grid infrastructure, and energy storage systems.
Trust Stamp Inc (NASDAQ:IDAI, ISE:AIID), the AI-powered identity and security firm, said on Tuesday it had completed two acquisitions aimed at strengthening its cybersecurity and risk-management technology offerings.
The company said it acquired 100% of the outstanding share capital of Lexverify Ltd in February 2026, and subscribed for a 50% ownership stake in Cyberfish CyberPsychology Solutions Ltd just this week.
Liberty Star Uranium & Metals Corp. (OTCQB:LBSR) (dba Liberty Star Minerals) said on Tuesday it has staked additional mineral exploration permits in Arizona, expanding its land position around the Hay Mountain project as the company seeks to advance targets for gold and other critical minerals.
The US-based exploration company said it has secured 13 additional mineral exploration permits covering just over 11 square miles in the Tombstone Mining District in southeast Arizona.
Standard Uranium Ltd (TSX-V:STND, OTCQB:STTDF, FRA:9SU0) said on Tuesday final assay results from its 2025 exploration program at the Rocas uranium project in Saskatchewan confirmed anomalous uranium and rare earth element mineralization across the property and will help guide an inaugural drilling campaign planned for March.
The fall 2025 program involved detailed mapping, prospecting and sampling across historical uranium showings and other target areas. The company said the work identified several zones of strong radioactivity and confirmed uranium mineralization in surface outcrop and boulder samples.
Replenish Nutrients Holding Corp (CSE:ERTH, OTC:VVIVF, FRA:7KE) announced that it has closed the second tranche of its previously announced non-brokered private placement, raising approximately $2.19 million in gross proceeds as the company looks to expand production and distribution of its regenerative fertilizer products.
The Okotoks, Alberta-based company said the financing supports its strategy to scale manufacturing at its Beiseker facility and advance licensing partnerships aimed at expanding its regenerative fertilizer footprint across Western Canada and the United States.
Immunic Inc (NASDAQ:IMUX, FRA:10VA) said on Tuesday the European Patent Office has granted a key patent covering dosing regimens for its experimental multiple sclerosis treatment vidofludimus calcium, extending potential market protection for the drug candidate in Europe to 2038.
The patent, EP3713554, protects label-relevant dosing regimens of vidofludimus calcium and broadly covers the compound and its salt, solvate and free acid forms when used according to the approved label, the company said. The protection could be extended potentially to 2043 if a Supplementary Protection Certificate is granted.
Investor backing strengthens capital base as group pursues expansion and platform development
SSV Capital, the financial services company, has raised more than £2.5 million after completing a funding round through the issue of 2 million preference ordinary shares.
AIM modelling company raises £450,000 at a steep discount, betting that investment in growth will justify near-term pain for shareholders
Shares in Physiomics, the AIM-listed mathematical modelling and data science company serving the pharmaceutical industry, fell 27% to 0.33p after it announced a placing at 0.3p per share, a discount of approximately 33% to the previous closing price, leaving the company valued at less than £1 million.
Active Energy Group PLC (AIM:AEG, OTCQB:ATGVF), the digital energy infrastructure company, has signed binding heads of terms to acquire a live grid connection site in Abu Dhabi for total of £2 million, subject to due diligence.
The Ghummud site comprises a 3.5 megavolt-ampere (MVA) energised grid connection with an active transformer and associated electrical infrastructure, providing approximately 2.975 megawatts (MW) of available power load.
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A), the UK solid-state battery pioneer, has completed its first revenue-generating delivery to Cirtec Medical, a contract manufacturer specialising in active implantable medical devices.
The company shipped an initial batch of commercial-grade Stereax electrodes to Cirtec, which announced a commercial supply arrangement with Ilika in January 2026 to support its M300 battery manufacturing.
Fortuna Metals Ltd (ASX:FUN, OTC:FRTMF) has reported further high-grade rutile intersections from first-pass drilling at its Mkanda rutile and graphite project in Malawi, with results confirming widespread mineralisation across multiple large anomalies.
Assays from 40 drillholes and 180 shallow 0–2 metre composite samples have returned several strong intercepts, including 8m at 1.15% rutile, 10m at 0.89% rutile and 10m at 0.83% rutile, with many holes remaining open at depth.
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) is drawing fresh attention to its experimental cancer therapy azer-cel after a Channel 10 news report highlighted a patient who entered remission following treatment in the company’s clinical trial.
The report followed Central Coast mother Judy Proctor, who had spent nearly a decade battling aggressive blood cancer and had exhausted standard treatment options before enrolling in the trial. Doctors involved in her care said that without another option she may have had only weeks to live.
Dimerix Ltd (ASX:DXB, OTC:SBMJF) has completed dosing the last adult patient in its ACTION3 Phase 3 trial of DMX-200 for focal segmental glomerulosclerosis (FSGS), with final adult enrolment reaching 333 patients, above the original target of 286.
Adult recruitment is now closed, while paediatric recruitment continues as a separate cohort in the study under arrangements agreed with regulators. Target adult recruitment and dosing had been completed in December 2025, but patients already in screening at that point were allowed to continue through to randomisation and dosing if eligible, resulting in the over-recruitment.
Arafura Rare Earths Ltd (ASX:ARU, OTC:ARAFF, FRA:REB) has progressed execution readiness for its Nolans rare earths project in the Northern Territory, announcing a land access compensation agreement, acquisition of camp infrastructure and a partnership to review alternative heavy rare earth separation technologies.
The company’s subsidiary, Arafura Nolans Project Pty Ltd, has entered into a compensation deed with ATAYF Pastoralists Pty Ltd, the holder of the pastoral lease covering the Nolans project site. As part of the agreement, ATAYF will receive A$4 million in Arafura shares and will also invest A$1.2 million in cash in the company.
Clinical-stage immuno-oncology company Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has reported encouraging early response rates from the CAR T-naïve cohort of its ongoing Phase 1b trial evaluating azer-cel, an off-the-shelf cell therapy being tested across several advanced B-cell cancers.
Early data from the study showed a 100% overall response rate (ORR) in patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma (CLL/SLL), while patients with marginal zone lymphoma (MZL) recorded an 80% ORR, including several complete responses.